Hyderabad is India’s bulk drug capital. Genome Valley, Patancheru-Bollaram, Jeedimetla, and the Pashamylaram corridor host hundreds of formulation, API, vaccine, and CDMO plants, from Aurobindo and Divi’s to Bharat Biotech and hundreds of mid-sized GMP units. What they share is a power bill that never sleeps: cleanroom HVAC, purified water systems, compressors, and 24/7 packaging lines push monthly electricity costs of ₹8 lakh to ₹80 lakh depending on plant size. With TSSPDCL industrial tariffs of ₹6.65 to 7.65 per kVAh in FY 2025-26 and steady annual escalation, solar is now one of the fastest-payback capital decisions a Hyderabad pharma CFO can make.
Direct answer. A 500 kWp rooftop solar system at a Hyderabad pharma plant costs ₹1.9 to 2.1 crore installed and saves ₹45 to 60 lakh per year at TSSPDCL HT-I tariffs of ₹6.65 to 7.65 per kVAh. With 40 percent accelerated depreciation, effective payback is 3 to 4 years. Telangana’s 2025 rooftop regulation allows net metering up to 500 kWp and gross or group metering up to 1 MWp, so most single-plant pharma units fit inside the rooftop framework.
This guide breaks down the tariffs, the 2025 policy changes, cleanroom-specific sizing, and the full ROI maths, using the same framework we apply across our industrial projects and in our sister guides for the Baddi pharma cluster and the Ankleshwar chemical cluster.
Why Hyderabad’s Pharma Belt Is Built for Solar
Hyderabad’s pharma geography concentrates exactly the load profile solar serves best: large, flat, RCC industrial rooftops with heavy, steady daytime consumption.
The clusters. Genome Valley (Shamirpet-Kompally) is India’s life-sciences R&D and vaccine hub, home to Bharat Biotech, Biological E, and dozens of biologics and clinical-research units. Patancheru-Bollaram, along the Mumbai highway, is the bulk-drug and API heartland with Aurobindo, MSN, and Divi’s operations in and around it. Jeedimetla, one of Asia’s older industrial estates, mixes formulations, intermediates, and packaging units. The upcoming Hyderabad Pharma City at Mucherla will add a mega SEZ to this belt. Telangana’s pharma exports keep growing, and every expansion adds HVAC and utility load.
The climate. Hyderabad receives 5.3 to 5.7 peak sun hours per day, among the best of any Indian metro, and better than Baddi’s 4.8 to 5.2 hours. A well-designed system delivers 1,500 to 1,600 kWh per kWp per year. Summer temperatures reduce panel efficiency slightly, but the city has no snow, mild winters, and low soiling outside the pre-monsoon dust season.
The load match. GMP manufacturing holds cleanrooms at 20 to 25 degrees Celsius with strict humidity and air-change rates, so HVAC runs continuously. Industry studies, including the US EPA’s ENERGY STAR pharmaceutical energy guide, put HVAC at roughly 60 to 65 percent of a pharma facility’s electricity use. Most of that load sits in the 8 AM to 7 PM window, which overlaps solar generation almost perfectly.
TSSPDCL Industrial Tariffs: What Your Plant Actually Pays
The single biggest driver of solar ROI in Hyderabad is the tariff you avoid. Southern Power Distribution Company of Telangana (TSSPDCL, now styled TGSPDCL) bills pharma plants under the HT-I(A) Industry General category. The TGERC Retail Supply Tariff Order for FY 2025-26 sets these rates:
| Voltage level | Demand charge (₹/kVA/month) | Energy charge, 10 AM to 6 PM (₹/kVAh) | Peak surcharge (₹/kVAh) | Night rebate (₹/kVAh) |
|---|---|---|---|---|
| 11 kV | 500 | 7.65 | +1.00 | -1.50 |
| 33 kV | 500 | 7.15 | +1.00 | -1.50 |
| 132 kV and above | 500 | 6.65 | +1.00 | -1.50 |
Peak hours are 6 AM to 10 AM and 6 PM to 10 PM; night hours are 10 PM to 6 AM, per the TGERC tariff order FY 2025-26. Electricity duty and customer charges come on top, so the effective all-in cost for an 11 kV pharma connection typically lands at ₹8.2 to 8.8 per unit in daytime hours.
Two details matter for solar planning. First, solar generates almost entirely inside the 10 AM to 6 PM normal-tariff band and the morning peak band, so every self-consumed unit displaces ₹7.65 to 8.65 of grid energy at 11 kV, not the cheaper night rate. Second, demand charges (₹500 per kVA) are largely unaffected by solar unless your peak demand itself falls in solar hours, which for many single-shift-heavy plants it does. Do not let an EPC promise demand-charge savings without interval data proving your billing demand peaks after 10 AM.
📘 Regulation note
Telangana has seen repeated industrial tariff hike proposals since 2024, and industry associations have publicly flagged rising power costs as a top risk. Tariff escalation of 4 to 5 percent a year is a realistic planning assumption, which improves solar ROI further because your avoided cost grows every year while your solar cost is fixed at commissioning.
Telangana’s 2025 Rooftop Solar Regulation: What Changed for Industry
Telangana replaced its 2016 rooftop framework with the TGERC Rooftop Solar PV Grid Interactive Systems Regulation, 2025, and the changes are material for pharma plants, as covered by Mercom India (2025) and Energetica India (2025):
- Net metering up to 500 kWp. Excess generation is credited against your bill at retail value (see how net metering billing works). This cap covers the majority of mid-sized formulation and packaging units.
- Gross metering up to 1 MWp. All generation is exported at a standardised tariff. Useful where roof rights are separated from consumption, for example leased sheds.
- Group net metering and virtual net metering. New for Telangana. A company with multiple meters or blocks in the same DISCOM area can pool generation credits across them. This is a real win for pharma campuses with separate meters for the API block, formulation block, and QC labs.
- Streamlined approvals. First-come-first-served feasibility processing, defined timelines, and named DISCOM nodal officers. Systems above 56 kWp require Chief Electrical Inspector (CEIG) certification before commissioning.
- Charge exemptions. Banking, wheeling, and cross-subsidy surcharges are waived under certain self-consumption arrangements, improving the effective value of each solar unit.
For plants wanting more than 500 kWp, the practical routes are gross metering, behind-the-meter captive with minimal export, or open-access and group-captive solar from an off-site park. Hyderabad pharma majors are already moving: Aurobindo Pharma announced in 2026 a captive solar investment of up to ₹10.4 crore through an equity stake in a solar SPV under Telangana’s captive power rules. Mid-sized plants can replicate the structure at smaller scale. Our industrial solar installation guide covers the captive versus rooftop decision in more depth.
Sizing Solar for Cleanroom and HVAC Loads: The Pharma Load-Split Sizing Rule
Pharma plants are not generic factories. Aseptic suites, stability chambers, and QC labs need clean, uninterrupted power, while water systems, chillers, and packaging lines tolerate normal grid variation. Sizing solar off the total sanctioned load, the most common EPC shortcut, oversizes the system and pushes export you cannot monetise well.
We use the Pharma Load-Split Sizing Rule, a four-step method we apply on every GMP site survey:
- Split the loads. Classify circuits into GMP-critical (cleanroom AHUs, aseptic filling, QC instruments, stability chambers) and utility (raw water and RO plants, chillers, compressors, packaging, canteen, offices). Utility loads are your primary solar targets.
- Log the 10 AM to 6 PM window. Pull 30 days of interval data from your TSSPDCL meter or a temporary logger. Solar value is set by this window because it is where generation and the normal energy charge overlap.
- Size at 70 percent of the daytime average. If your 10 AM to 6 PM average load is 700 kW, install roughly 500 kWp. This keeps self-consumption above 85 percent even on low-production days and respects the 500 kWp net metering cap.
- Confirm roof and structure. A 500 kWp system needs about 3,000 to 3,500 square metres of shadow-free roof. Check for HVAC exhaust stacks, cooling towers, and vent stacks that cast shade or deposit chemical-laden dust on panels.
A worked example: a formulation unit in Jeedimetla with a ₹28 lakh monthly bill, 1,000 kVA contract demand at 11 kV, and a measured daytime average load of 680 kW. The rule says install about 480 to 500 kWp. That generates roughly 7.4 lakh kWh per year at Hyderabad’s yield, displacing about ₹56 lakh of grid energy in year one.
💡 Fast tip
Ask your EPC to model the ToD bands explicitly. A system that exports heavily at midday but leaves your 6 PM to 10 PM peak untouched is leaving money on the table. Shifting compressors or chilled-water storage into solar hours can raise effective savings 5 to 8 percent without adding a single panel.
Get a free load-split audit for your plant. Our engineers review 12 months of TSSPDCL bills and interval data, then deliver a sized proposal with tariff-band-level savings in 72 hours. Get your free quote →
What a 500 kWp System Costs in Hyderabad (2026)
Installed costs in Hyderabad are close to Gujarat plains pricing because logistics are easy and skilled labour is available, unlike hill clusters such as Baddi where logistics add 15 to 20 percent. A realistic Q3 2026 budget for a 500 kWp rooftop system at a pharma plant:
| Component | Cost per kWp | 500 kWp total |
|---|---|---|
| Modules (580W TOPCon, ALMM listed) | ₹18,500 | ₹92.5 lakh |
| String inverters (3-phase, low THD) | ₹5,500 | ₹27.5 lakh |
| Mounting (ballasted over GMP roofs, penetrating elsewhere) | ₹4,500 | ₹22.5 lakh |
| DC/AC cabling | ₹3,000 | ₹15 lakh |
| ACDB, DCDB, earthing, SPD, lightning protection | ₹1,800 | ₹9 lakh |
| Civil, waterproofing, and safety works | ₹2,200 | ₹11 lakh |
| Labour and project management | ₹2,500 | ₹12.5 lakh |
| TSSPDCL net metering, CEIG approval, liaison | ₹1,200 | ₹6 lakh |
| Total installed | ₹39,200/kWp | ₹1.96 crore |
Two pharma-specific cost lines deserve attention. Ballasted, non-penetrating mounting over cleanroom roofs costs a little more and adds dead load, so a structural check of the roof slab is mandatory; the ballasted versus penetrating mounting comparison from Heaven Designs explains the engineering trade-off. And inverters feeding panels shared with analytical instruments must hold total harmonic distortion under 3 percent, which rules out the cheapest string inverters; the Qbits inverter specifications guide walks through THD, power factor, and protection ratings worth specifying in your BOQ.
ROI Analysis: Payback, IRR, and Accelerated Depreciation
Assumptions for the model: 500 kWp, ₹1.96 crore capex, 1,520 kWh/kWp/year specific yield, 90 percent self-consumption valued at ₹7.9 per unit all-in, 10 percent exported at the gross or surplus tariff of roughly ₹3.5 per unit, 5 percent annual tariff escalation, 0.45 percent annual degradation, and O&M at 1 percent of capex.
| Year | Generation (kWh) | Bill saving (₹lakh) | AD tax saving (₹lakh) | Net cash flow (₹lakh) |
|---|---|---|---|---|
| 1 | 7,60,000 | 56.5 | 19.6 | 76.1 |
| 2 | 7,56,600 | 59.3 | - | 59.3 |
| 3 | 7,53,200 | 62.3 | - | 62.3 |
| 4 | 7,49,800 | 65.4 | - | 65.4 |
| 5 | 7,46,400 | 68.7 | - | 68.7 |
| 5-year cumulative | ₹3.12 crore | ₹19.6 lakh | ₹3.32 crore |
Payback lands at about 2.8 to 3.2 years with accelerated depreciation and 3.6 to 4 years without it. Project IRR over 25 years typically exceeds 25 percent, far above the 12 to 14 percent hurdle most pharma CFOs apply to plant capex. One nuance: the 40 percent AD benefit only helps if your company has taxable profits under the old regime; companies that have opted for the 22 percent concessional regime under Section 115BAA cannot claim AD, so run both cases with your CA before fixing the financial model.
Verdict. For any Hyderabad pharma plant with more than 3,000 square metres of usable roof and a monthly bill above ₹15 lakh, rooftop solar under net metering is the highest-certainty capital project available in 2026. Above 1 MW of requirement, compare rooftop plus group-captive open access before committing the full load to one structure.
CAPEX vs OPEX vs Captive: Which Ownership Model Fits Your Plant
Pharma CFOs in Hyderabad have three real options, and the right answer depends on balance-sheet appetite and roof quality rather than on any universal winner.
| Dimension | CAPEX (own the plant) | OPEX / RESCO (PPA) | Group-captive open access |
|---|---|---|---|
| Upfront cost | ₹39,000/kWp | Zero | 26% equity in SPV |
| Tariff benefit | Full ₹7.9+/unit offset | ₹1.5-2.5/unit discount | ₹3-4/unit net saving |
| Payback | 3-4 years | Immediate savings | 4-6 years on equity |
| AD benefit | Yours (40% Year 1) | Developer’s | Partial, via SPV |
| Size limit | 500 kWp net metering | Roof or land dependent | No practical limit |
| Best for | Cash-rich, owned premises | Leased sheds, capital-constrained | Plants needing 1 MW+ |
The OPEX vs CAPEX solar comparison goes deeper into contract traps, but the short version: under RESCO you sign a 15 to 25 year PPA at ₹4.5 to 5.5 per unit, saving roughly ₹2 per unit from day one with zero investment, while giving up two-thirds of the lifetime value to the developer. Captive open access suits the large API plants around Patancheru that need 2 to 10 MW and have land-poor sites. Aurobindo’s 2026 SPV investment is exactly this structure.
⚠️ Watch out
Installer complaints on X about TSSPDCL net-meter delays are real: plants report 4 to 10 week waits between installation and meter commissioning, during which generated power earns nothing. Insist your EPC contract makes liaison and meter commissioning their responsibility, with the payment milestone tied to net-meter installation, not panel installation.
GMP, Cleanroom, and Audit Considerations Specific to Pharma
Pharma solar projects fail on compliance details that generic industrial EPCs miss. Four points from our GMP project experience:
Roof integrity over cleanrooms. Penetrating mounts are not acceptable over validated cleanroom or aseptic areas because they breach the roof membrane and create contamination and leak risk. Use ballasted systems there, penetrating systems over warehouses and utility blocks, and document the structural calculations for your facility file.
Power quality. HPLC, GC-MS, and dissolution systems are sensitive to harmonics. Specify inverters with THD under 3 percent and keep solar ACDBs electrically separated from QC lab panels. This costs little and prevents the chromatography ghost peaks that cheap inverters can cause.
Documentation for FDA and EMA audits. Auditors rarely inspect the solar plant itself, but your electrical single-line diagram and Drawing Control documentation must reflect the modified distribution. Keep the commissioning report, CEIG certificate, and inverter certifications in your facility qualification dossier.
ESG reporting value. A 500 kWp system avoids roughly 620 tonnes of CO2 per year at India’s grid emission factor of about 0.82 kg per kWh (CEA, 2024-25). For exporters facing EU and US buyer sustainability questionnaires, CDP disclosures, or SEBI’s BRSR for listed companies, that is reportable Scope 2 reduction from year one, not an offset you had to buy. MNRE’s national rooftop programme data also shows industrial rooftops are among the fastest-growing segments, which keeps improving the ALMM module supply chain you will buy from.
Pros and Cons of Solar for Hyderabad Pharma Plants
- ✓ High daytime HT-I tariff (₹7.65/kVAh at 11 kV) makes every solar unit valuable
- ✓ Strong irradiation, 5.3 to 5.7 peak sun hours, better than most metros
- ✓ 2025 regulation adds group and virtual net metering for multi-block campuses
- ✓ 40% AD cuts Year 1 net outlay; 3 to 4 year payback
- ✓ Direct Scope 2 reduction for FDA-buyer ESG questionnaires and BRSR
- ✗ 500 kWp net metering cap limits large API plants unless they go gross or captive
- ✗ Net-meter commissioning delays of 4 to 10 weeks reported with TSSPDCL
- ✗ Cleanroom roofs restrict mounting and add structural verification cost
- ✗ Section 115BAA companies forfeit the AD benefit, lengthening payback
- ✗ Chemical dust near API blocks raises cleaning frequency and O&M cost
How Heaven Green Energy Helps
Heaven Green Energy executes industrial solar EPC projects across India, including pharma clusters where GMP constraints, low-THD inverter specification, CEIG approvals, and DISCOM liaison decide whether a project finishes in 90 days or drifts for a year. For Hyderabad pharma plants we start with a free load-split audit: 12 months of TSSPDCL bills, interval-data logging, a structural roof check, and a 25-year financial model with and without AD, delivered in 72 hours. We handle the full TSSPDCL net metering application, CEIG certification for systems above 56 kWp, and commissioning documentation formatted for your facility qualification files.
- Industrial Solar EPC: 100 kW to multi-MW turnkey projects with performance guarantees and GMP-aware installation practices.
- Commercial Solar: 10 to 100 kW systems for QC labs, offices, and ancillary blocks.
- Solar Calculator: model your plant’s savings from your monthly bill in 60 seconds.
- Solar for hospitals: the parallel guide for another 24/7 critical-load sector with similar HVAC dominance.
Ready to cut your plant’s power cost by 40 to 50 percent? Talk to our industrial solar engineer about your Hyderabad facility. Call +91 63904 05060 or request a callback.
Frequently Asked Questions
What is the TSSPDCL industrial tariff for pharma plants in Hyderabad in FY 2025-26?
Pharma plants fall under HT-I(A) Industry General. The TGERC FY 2025-26 order sets energy charges of ₹7.65 per kVAh at 11 kV, ₹7.15 at 33 kV, and ₹6.65 at 132 kV and above for the 10 AM to 6 PM band, plus a demand charge of ₹500 per kVA per month. Peak hours (6 to 10 AM and 6 to 10 PM) add ₹1.00 per kVAh, and night hours get a ₹1.50 rebate. With duty and surcharges, daytime all-in cost typically reaches ₹8.2 to 8.8 per unit.
What is the maximum rooftop solar size under net metering in Telangana?
Under the TGERC Rooftop Solar Regulation 2025, net metering is allowed up to 500 kWp and gross metering up to 1 MWp. Plants needing more capacity can use group net metering or virtual net metering across multiple meters, behind-the-meter captive systems with minimal export, or open-access and group-captive structures for multi-MW requirements.
How much does a 500 kWp solar plant cost at a Hyderabad pharma unit?
A 500 kWp rooftop system costs approximately ₹1.9 to 2.1 crore installed in Hyderabad in 2026, or about ₹39,000 to 42,000 per kWp. That includes ALMM-listed TOPCon modules, low-THD string inverters, ballasted mounting over GMP roof areas, civil works, and TSSPDCL net metering plus CEIG liaison. Pharma-specific requirements like ballasted mounting and premium inverters add modestly to generic industrial pricing.
What is the payback period for solar at a Hyderabad pharma plant?
With a daytime tariff of ₹7.65 to 8.65 per kVAh avoided and 1,500 to 1,600 kWh per kWp per year of generation, a 500 kWp system pays back in about 2.8 to 3.2 years with 40 percent accelerated depreciation, or 3.6 to 4 years without it. Companies taxed under Section 115BAA cannot claim AD, so they should model the longer payback case.
Can solar panels be installed over a GMP cleanroom roof?
Yes, but only with ballasted, non-penetrating mounting that preserves the roof membrane and cleanroom air-tightness. The roof slab must pass a structural check for the added dead load. Penetrating mounts are used over warehouses, utility blocks, and non-validated areas. Structural calculations and the mounting method should be documented in your facility qualification file for FDA or EMA audit readiness.
Does solar reduce TSSPDCL demand charges?
Usually not directly. Demand charges of ₹500 per kVA are set by your billing demand, and solar only reduces it if your maximum demand occurs during solar generation hours. Plants whose peak load falls in the morning production ramp (after 10 AM) can see real demand-charge savings; plants peaking in the evening shift will not. Check interval data before accepting any demand-charge savings claim.
Is OPEX or CAPEX better for a leased pharma facility in Hyderabad?
For leased premises, OPEX or RESCO structures usually fit better because the developer owns and maintains the plant and you buy power at ₹4.5 to 5.5 per unit under a 15 to 25 year PPA, saving roughly ₹2 per unit from day one with zero capex. CAPEX delivers two to three times more lifetime value but makes most sense when you own the building and have taxable profits to absorb accelerated depreciation.
How does solar help pharma ESG and export compliance?
Solar generation directly reduces Scope 2 emissions reported under the GHG Protocol. A 500 kWp system avoids about 620 tonnes of CO2 per year at India’s grid emission factor of 0.82 kg per kWh (CEA, 2024-25). This feeds BRSR disclosures for listed companies, CDP submissions, EcoVadis scores, and sustainability questionnaires that US and EU pharma buyers increasingly require from Indian suppliers.
